American Journal of Kidney Diseases
Volume 55, Issue 2 , Pages 291-299 , February 2010

Kidney Function and Rate of Bone Loss at the Hip and Spine: The Canadian Multicentre Osteoporosis Study

  • Sophie A. Jamal, MD, PhD

      Affiliations

    • University of Toronto, Toronto, Canada
    • Corresponding Author InformationAddress correspondence to Sophie A. Jamal, MD, PhD, 76 Grenville St, Ste 805, Toronto, Ontario, Canada
    • ,
  • Victoria J.D. Swan, BSc, BPHE

      Affiliations

    • Women's College Hospital, Toronto, Canada
    • ,
  • Jacques P. Brown, MD

      Affiliations

    • Laval University, Quebec, Canada
    • ,
  • David A. Hanley, MD

      Affiliations

    • University of Calgary, Calgary, Canada
    • ,
  • Jerilynn C. Prior, BA, MD

      Affiliations

    • University of British Columbia, Vancouver, Canada
    • ,
  • Alexandra Papaioannou, MD, MSc

      Affiliations

    • McMaster University, Hamilton, Canada
    • ,
  • Lisa Langsetmo, PhD

      Affiliations

    • McGill University, Montreal, Canada
    • ,
  • Robert G. Josse, MD

      Affiliations

    • University of Toronto, Toronto, Canada
    • ,
  • Canadian Multicentre Osteoporosis Study Research Group

Received 24 April 2009 ,Accepted 27 October 2009.

References 

  1. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  2. Jamal S. Fractures in men and women with dialysis-dependent renal failure. Endocrinol Rounds. 2003;3:1–6
  3. Jamal SA, Gilbert J, Gordon C, Bauer DC. Cortical PQCT measures are associated with fractures in dialysis patients. J Bone Miner Res. 2006;21:543–548
  4. Jamal SA, Leiter RE, Jassal V, Hamilton CJ, Bauer DC. Impaired muscle strength is associated with fractures in hemodialysis patients. Osteoporosis Int. 2006;17:1390–1397
  5. Malluche HH, Faugere MC. Renal osteodystrophy. N Engl J Med. 1989;321:317–318
  6. Lindberg JS, Moe SM. Osteoporosis in end-state renal disease. Semin Nephrol. 1999;19:115–122
  7. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T. Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis. 1999;33:287–293
  8. Chan YL, Furlong TJ, Cornish CJ, Posen S. Dialysis osteodystrophy (A study involving 94 patients). Medicine (Baltimore). 1985;64:296–309
  9. Schaab PC, Murphy G, Tzamaloukas AH, et al. Femoral neck fractures in patients receiving long-term dialysis. Clin Orthop. 1990;260:224–231
  10. Vonesh EF, Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1999;10:354–365
  11. Eknoyan G. Cardiovascular mortality and morbidity in dialysis patients. Miner Electrolyte Metab. 1999;25:100–104
  12. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis. 2000;36:1115–1121
  13. Jamal SA, Hayden JA, Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis. 2007;49:674–681
  14. Yamaguchi T, Kanno E, Tsubota J, Shiomi T, Nakai M, Hattori S. Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone. 1996;19:549–555
  15. Fontaine MA, Albert A, Dubois B, Saint-Remy A, Rorive G. Fracture and bone mineral density in hemodialysis patients. Clin Nephrol. 2000;54:218–226
  16. Jamal S, Chase C, Goh Y, Richardson R, Hawker G. Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am J Kidney Dis. 2002;39:843–849
  17. Kaji H, Suzuki M, Yano S, et al. Risk factors for hip fracture in hemodialysis patients. Am J Nephrol. 2002;22:325–331
  18. Urena P, Bernard-Poenaru O, Ostertag A, et al. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant. 2003;18:2325–2331
  19. Inaba M, Okuno S, Kumeda Y, Yamakawa T, Ishimura E, Nishizawa Y. Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus. Calcif Tissue Int. 2005;76:256–260
  20. Rix M, Andreassen H, Eskildsen P, Bente L, Olgaard K. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int. 1999;56:1084–1093
  21. Hsu CY, Cummings SR, McCulloch CE, Chertow GM. Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. Kidney Int. 2002;61:1814–1820
  22. Ishani A, Paudel M, Taylor BC, et al. Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Osteoporos Int. 2008;19:1549–1556
  23. Jassal SK, von Muhlen D, Barrett-Connor E. Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res. 2007;22:203–210
  24. Krieger N, Tenehouse A, Joseph L, et al. Research notes: the Canadian Multicentre Osteoporosis Study (CaMOS): background, rationale, methods. Can J Aging. 1999;18:376–387
  25. VITROS Chemistry Product: Calcium Test Methodology. Rochester, NY: Ortho-Clinical Diagnostics Johnson & Johnson; 2004;
  26. VITROS Chemistry Product: Phosphorous Test Methodology. Rochester, NY: Ortho-Clinical Diagnostics Johnson & Johnson; 2004;
  27. Fiske CH, Subbarow Y. The colorimetric determination of phosphorous. [abstract] J Biol Chem. 1925;66:375
  28. Goromy G. A modification of the colorimetric phosphorous determination for use with a photoelectric colorimeter. [abstract] J Lab Clin Med. 1942;27:955
  29. VITROS Chemistry Product: Creatinine Test Methodology. Rochester, NY: Ortho-Clinical Diagnostics Johnson & Johnson; 2004;
  30. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  31. DuBois D, Dubouis E. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;17:863–871
  32. Ware JEJ. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute; New England Medical Center; 1993;
  33. Kiel D. Assessing vertebral fractures (National Osteoporosis Foundation Working Group on Vertebral Fractures). J Bone Miner Res. 1995;10:518–523
  34. Jackson SA, Tenenhouse A, Robertson L. Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int. 2000;11:680–687
  35. Papaioannou A, Joseph L, Ioannidis G, et al. Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int. 2005;16:568–578
  36. Cummings SR, Cosman F, Jamal SA. Osteoporosis (An Evidenced-Based Guide to Prevention and Management). Philadelphia, PA: American College of Physicians; 2002;
  37. Yendt ER, Cohanim M, Jarzylo S, Jones G, Rosenberg G. Bone mass is related to creatinine clearance in normal elderly women. J Bone Miner Res. 1991;6:1043–1050
  38. Vassalotti JA, Uribarri J, Chen SC, et al. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008;51(suppl 2):S56–S68

 Originally published online as doi:10.1053/j.ajkd.2009.10.049 on December 31, 2009.

PII: S0272-6386(09)01447-4

doi: 10.1053/j.ajkd.2009.10.049

American Journal of Kidney Diseases
Volume 55, Issue 2 , Pages 291-299 , February 2010

Article Tools

* Image Usage & Resolution